Address
Email address
https://sydameapteek.eeKõik ravimid Südameapteegi e-apteegistSüdameapteegi e-apteek: telli mugavalt ravimid, toidulisandid, vitamiinid ja apteegikosmeetika pakiautomaati, apteeki või koju. Tarne alates 0 eurot.
Name
Krooniapteek OÜ
Registry code
14921715
VAT number
EE102241974
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
26.02.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
5 339 875 €
58 212 €
1%
-
235 839 €
15
Submitted
No tax arrears
25%
5%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Aime Teder 01.09.1972 (52) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| 2020 30.06.2021 | 2021 08.04.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 3 306 869 € | 4 537 205 € | 4 971 113 € | 5 339 875 € |
| Net profit (loss) for the period | 32 042 € | 71 749 € | 73 835 € | 58 212 € |
| Profit Margin | 1% | 2% | 1% | 1% |
| Current Assets | 598 354 € | 554 941 € | 908 300 € | 1 000 222 € |
| Fixed Assets | 230 000 € | 230 000 € | 230 000 € | 230 000 € |
| Total Assets | 828 354 € | 784 941 € | 1 138 300 € | 1 230 222 € |
| Current Liabilities | 796 312 € | 681 150 € | 960 673 € | 994 383 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 32 042 € | 103 791 € | 177 627 € | 235 839 € |
| Employees | 15 | 16 | 15 | 15 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 1 562 657.96 € | 62 641.82 € | 50 943.14 € | 19 |
| 2023 Q4 | 1 522 064.87 € | 57 007.72 € | 46 500.52 € | 20 |
| 2023 Q3 | 1 358 592.72 € | 58 579.39 € | 52 617.43 € | 20 |
| 2023 Q2 | 1 439 919.98 € | 55 642.58 € | 43 352.47 € | 20 |
| 2023 Q1 | 1 416 941.92 € | 62 331.47 € | 51 528.91 € | 20 |
| 2022 Q4 | 1 385 827.15 € | 53 346.36 € | 44 521.33 € | 21 |
| 2022 Q3 | 1 241 465.83 € | 58 601.68 € | 52 019.34 € | 20 |
| 2022 Q2 | 1 322 567.22 € | 59 410.19 € | 46 266.19 € | 22 |
| 2022 Q1 | 1 360 261.91 € | 64 385.09 € | 51 655.18 € | 22 |
| 2021 Q4 | 1 354 956.08 € | 59 633.19 € | 45 115.84 € | 20 |
| 2021 Q3 | 1 162 873.73 € | 55 545.1 € | 47 533.4 € | 20 |
| 2021 Q2 | 1 162 803.59 € | 47 292.06 € | 36 291.72 € | 20 |
| 2021 Q1 | 1 194 216.62 € | 54 733.37 € | 47 590.19 € | 21 |
| 2020 Q4 | 1 269 863.38 € | 46 781.17 € | 38 534.74 € | 20 |
| 2020 Q3 | 1 072 616.33 € | 42 191.14 € | 40 784.04 € | 20 |
| 2020 Q2 | 707 342.74 € | 22 798.61 € | 15 645.01 € | 20 |
| 2020 Q1 | - | - | - | 21 |
